A Multi-centre, Multi-national Open Study in Patients With Hepatic Cirrhosis to Characterise the Association Between the Pharmacokinetics of NRL972 and Disease Severity.
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Cholyl lysyl fluorescein (Primary)
- Indications Liver cirrhosis
- Focus Pharmacokinetics
- Sponsors Norgine
Most Recent Events
- 21 May 2014 New trial record